Pfizer and BioNTech to Offer COVID-19 Vaccine to Participants Who Got Placebo – Report
Pfizer and its German partner BioNTech are planning to offer the
first dose of its investigational COVID-19 vaccine by March 1, 2021
to those volunteers who received a placebo in its vaccine trial,
Reuters reported. Notably, Pfizer (PFE) and BioNTech’s
investigational COVID-19 vaccine has not been approved or licensed
by the U.S. Food and Drug Administration (FDA). However, on Dec.
11, the U.S. FDA authorized Pfizer-BioNTech to provide the
investigational vaccine for emergency use in individuals aged 16
years and older.